Kanion's Kanion USA Inc. U.S. subsidiary granted NewGen development and commercialization rights to three preclinical cancer programs in territories outside of China

Kanion Pharmaceutical Co. Ltd.

China / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

NewGen Therapeutics Inc.

U.S. / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced